Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1125
http://purl.obolibrary.org/obo/NCIT_C1125
|
|---|---|
| Preferred Name | Hexamethylene Bisacetamide |
| Definitions |
A hybrid polar-planar compound with potential antineoplastic activity that induces terminal differentiation, inhibits cell growth, and causes apoptosis in several tumor cell lines. Its precise mechanism of action is unknown. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A hybrid polar-planar compound with potential antineoplastic activity that induces terminal differentiation, inhibits cell growth, and causes apoptosis in several tumor cell lines. Its precise mechanism of action is unknown. (NCI04) |
|---|---|
| prefLabel | Hexamethylene Bisacetamide
|
| label | Hexamethylene Bisacetamide
|
| PDQ_Closed_Trial_Search_ID | 39990
|
| code | C1125
|
| prefixIRI | NCIT:C1125
|
| in_subset | |
| Preferred_Name | Hexamethylene Bisacetamide
|
| FDA_UNII_Code | LA133J59VU
|
| Contributing_Source | FDA
|
| Maps_To | Hexamethylene Bisacetamide
|
| CAS_Registry | 3073-59-4
|
| NSC Number | 95580
|
| NCI_Drug_Dictionary_ID | 39990
|
| Legacy Concept Name | Hexamethylene_Bisacetamide
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 39990
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C0062641
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |